News - POCTRN

In response to the COVID-19 pandemic, the RADx program was formed to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19.

Learn More >>

Aset Penerbit

NIH LIVE QA Session

RADX Delivering new COVID-19 Testing Tech to Meet US Demand

NIH delivering new COVID-19 testing technologies to meet U.S. demand

Range of new technologies will meet testing needs in diverse settings

Rapid Scaling Up of Covid-19 Diagnostic Testing in the United States — The NIH RADx Initiative

The capital will be used to scale up testing capacity of PathogenDx's Microarray Assay for COVID-19 testing nationally

RADx Tech COVID19 Webinar Series: Regulatory Affairs on the RADx Frontlines

Perspective from a Point-of-Care Technology Research Center

Rapid Scaling Up of Covid-19 Diagnostic Testing in the United States — The NIH RADx Initiative

3M and MIT Researchers Developing a Rapid Diagnostic Test for COVID-19

The goal is a new, highly accurate, mass-produced low-cost diagnostic device that delivers results in minutes.

RADx Tech COVID19 Webinar Series: As the Coronavirus Pandemic Unfolds...

User Centered Design for the Rapid Acceleration of Diagnostics for COVID19

C-THAN Awardee Named Finalist for Blavatnik National Awards

Julius Lucks is one of three professors at Northwestern recognized as exceptional young researchers  

Webinar: Rapid Acceleration of the Diagnosis of COVID-19: New Technologies for the Re-opening of Businesses and Schools

July 10, 2020 12:00PM CT/1:00PM ET

RADx Tech COVID19 Webinar Series: As the Coronavirus Pandemic Unfolds...

The Challenges of COVID-19 / SARS-CoV-2 Diagnostics

RADx-UP Funding Opportunities and Webinar

Big Company Little Company Strategic Partnerships Showcase Event

Francis Collins Testifies Before Congress, May 7, 2020

Shark Tank: New Tests for COVID-19

COVID-19 Funding Opportunity: RADx Fast-Track Program for COVID-19 Test Development and Distribution

Innovative Technologies to Increase U.S. Capacity for COVID-19 Testing

NIH Announces $1 Million Prize Competition to Target Global Disease Diagnostics

Bill & Melinda Gates Foundation to offer supplementary support for designs that can be developed into products on a rapid timeframe

POCTRN CRAASH 2020

Check out the scenes from the kick-off session.

C-THAN Second Annual Symposium

January 27-30, 2020, Cape Town, South Africa at River Club

2019 CAPCaT Awardee and 2019 M2D2 $200K Challenge Winner Respirix

Catching up with $200K Challenge Winner

Johns Hopkins Funded Luminostics to Receive $10,000 Prize and Recognition from the Rapid Point-of-Care Diagnostics Industry

ASCB Biotech Courses

Applications Open February 2020